Long macaque breeding cycles and fully pre-booked colonies have forced some researchers to halt their critical studies.
UnitedHealth earnings Q2 2026 blew past Wall Street with adjusted EPS of $6.38 — 31% above consensus — as the company’s $1.5 ...
Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced the U.S. Food and Drug ...
Morning Overview on MSN
A drug-resistant fungus called Candida auris is spreading through American hospitals
Patients in American hospitals and long-term care facilities face a growing threat from Candida auris, a drug-resistant ...
New world screwworm is spreading in the U.S. The FDA has just authorized a new way to fight the deadly parasites, with a ...
Officials are still trying to determine the source of the cyclosporiasis outbreak as at least 102 people in Michigan have ...
On July 2, 2026, CMS issued a proposed rule with updates to the Medicare payment rates for the Hospital Outpatient Prospective Payment System ...
We like to believe our health decisions are guided by science. Yet history — and modern social media — suggests that fame ...
As federal officials consider whether to reclassify marijuana under federal drug law, a new study has found that more ...
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.
Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results